La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Hingham Institution a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Hingham Institution..

Hingham Institution (NASDAQ:HIFS) Azioni, Catena delle Opzioni

Hingham Institution

Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.

Hingham Institution for Savings - Common Stock

Hingham Institution for Savings

Hingham Institution (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIFS#NASDAQ">HIFS</a>) reported quarterly earnings of $2.16 per share. This is a 154.12 percent increase over earnings of $0.85 per share from the same period last year. The company reported $13.44 million in sales this quarter. This is a 43.37 percent increase over sales of $9.38 million the same period last year.

Earnings

News

HIFS

Hingham Institution Q4 Adj. EPS $2.16 Up From $0.85 YoY, Sales $13.44M Up From $9.38M YoY

WIIM

ABCB

ACNB

AMAL

AMTB

AROW

BANF

BANR

BCAL

BFST

BHLB

BHRB

BMRC

BOKF

BPOP

BRKL

BSRR

BSVN

BUSE

CARE

CASH

CATY

CBAN

CBNK

CBSH

CCBG

CCNE

CFFN

CHCO

CLBK

CNOB

COFS

CTBI

CUBI

CVBF

CZFS

DCOM

EBTC

EFSC

EGBN

EQBK

EWBC

FBIZ

FBMS

FBNC

FCBC

FCNCA

FFBC

FFIC

FFIN

FFWM

FIBK

FISI

FLIC

FMAO

FMBH

FMNB

FNLC

FRBA

FRME

FRST

FSBC

GABC

GBCI

GCBC

GNTY

GSBC

HAFC

HBCP

HBNC

HFBL

HFWA

HMST

HOMB

HONE

HOPE

HTBI

HTBK

HTLF

Shares of banking-related companies are trading higher after Donald Trump won the US presidential election.

Hingham Institution (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIFS#NASDAQ">HIFS</a>) reported quarterly earnings of $1.44 per share. This is a 9.09 percent increase over earnings of $1.32 per share from the same period last year. The company reported $11.26 million in sales this quarter. This is a 4.28 percent decrease over sales of $11.76 million the same period last year.

Hingham Institution Q3 Adj $1.44 Up From $1.32 YoY, Sales $11.26M Down From $11.76M YoY

BANC

BBDO

FULT

IBTX

INDB

KRNY

MOFG

NBTB

NYCB

PPBI

RBCAA

SBCF

SFBS

SFNC

TCBI

TRMK

UMBF

WSFS

Shares of banking companies are trading higher amid overall market strength following Fed Chair Powell's comments about the economy and future rate cuts.

Hingham Institution (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIFS#NASDAQ">HIFS</a>) reported quarterly earnings of $1.00 per share. This is a 45.95 percent decrease over earnings of $1.85 per share from the same period last year.

Hingham Institution Q2 Adj $1.00 Down From $1.85 YoY

Hingham Institution (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIFS#NASDAQ">HIFS</a>) reported quarterly earnings of $1.01 per share. This is a 61.3 percent decrease over earnings of $2.61 per share from the same period last year.

Hingham Institution Q1 Adj EPS $1.01 Down From $2.61 YoY

BSBR

CADE

COLB

FITB

GBNY

IBOC

ITUB

SASR

TOWN

UCBI

ZION

Shares of several bank stocks are trading lower after January CPI data showed a greater-than-expected rise in inflation, which increased uncertainty surrounding future rate cuts.

SMBC

Shares of banking companies are trading lower amid overall market weakness after the Federal Reserve left rates unchanged.

Hingham Institution For Savings shares are trading lower after the company reported a year-over-year decrease in Q4 financial results.

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects United Airlines Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ual#NASDAQ">UAL</a>) to report quarterly earnings at $1.70 per share on revenue of $13.54 billion after the closing bell. United Airlines shares fell 0.3% to $38.70 in after-hours trading.
Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) filed for offering of up to 1 million Class A common shares by the selling stockholder. Nxu shares fell 1.6% to $1.24 in the after-hours trading session.
Analysts are expecting Brown &amp; Brown, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) to earn 53 cents per share on revenue of $985.48 million for the latest quarter. The company will release earnings after the markets close. Brown &amp; Brown shares rose 0.8% to $75.39 in after-hours trading.
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
Hingham Institution for Savings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hifs#NASDAQ">HIFS</a>) posted core net income of 85 cents per share for the fourth quarter, down from $4.42 per share in the year-ago period. Hingham Institution shares gained 1% to close at $187.99 on Friday.
Analysts expect Zions Bancorporation, National Association (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zion#NASDAQ">ZION</a>) to post quarterly earnings at 99 cents per share on revenue of $756.61 million after the closing bell. Zions Bancorporation shares fell 0.1% to $41.57 in after-hours trading.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36690939/jim-cramer-predicts-a-terrific-year-for-this-manufacturer-and-as-for-u-haul-im-fine-with"> Jim Cramer Predicts A &#39;Terrific Year&#39; For This Manufacturer, And As For U-Haul? &#39;I&#39;m Fine With It&#39; </a>

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

United Airlines, Brown & Brown And 3 Stocks To Watch Heading Into Monday

Hingham Institution (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIFS#NASDAQ">HIFS</a>) reported quarterly earnings of $0.85 per share. This is a 80.77 percent decrease over earnings of $4.42 per share from the same period last year. The company reported $9.38 million in sales this quarter. This is a 55.26 percent decrease over sales of $20.95 million the same period last year.

Hingham Institution Q4 Adj $0.85 Down From $4.42 YoY, Sales $9.38M Down From $20.95M YoY

AGNC

ALLY

APAM

ATLC

BCOW

BSBK

CMTG

CURO

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HBAN

MKTX

NTRS

OPRT

PNFP

TREE

TROW

TRUP

UPST

VALU

VBFC

Shares of financial stocks are trading higher amid strong market sentiment following the Fed's decision to leave rates unchanged.

BYFC

CACC

COIN

GDOT

MSCI

NDAQ

PRAA

SOFI

TFSL

Shares of broader financial stocks are trading higher amid overall market strength after the Fed left rates unchanged and most Fed officials expect rate cuts in 2024-2026.

Hingham Institution For Savings shares are trading lower after the company reported a year-over-year decrease in Q3 EPS results.

Hingham Institution (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIFS#NASDAQ">HIFS</a>) reported quarterly earnings of $1.32 per share. This is a 79.94 percent decrease over earnings of $6.58 per share from the same period last year.

Hingham Institution Q3 EPS $1.32 Down From $6.58 YoY

BBVA

CATC

OCFC

STEL

UVSP

Shares of broad financial stocks are trading higher after Western Alliance released an investor update showing QTD deposit growth exceeded $2 billion as of May 12th. This has helped ease some ongoing concerns over the financial sector.

<h3>Gainers</h3>
<ul>
<li>SAI.TECH Global Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sai#NASDAQ">SAI</a>) jumped 269% to $5.61 after gaining around 25% on Thursday.</li>
<li>CXApp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxai#NASDAQ">CXAI</a>) shares jumped 138% to $16.80 after gaining more than 345% on Thursday.</li>
<li>mCloud Technologies Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcld#NASDAQ">MCLD</a>) surged 74% to $0.5902. mCloud recently received a non-compliance notice from Nasdaq.</li>
<li>Marpai, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrai#NASDAQ">MRAI</a>) gained 68.1% to $2.74 after gaining 90% on Thursday.</li>
<li>Peakstone Realty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pkst#NYSE">PKST</a>) rose 65.5% to $19.29. Peakstone Realty Trust announced listing of common shares on the New York Stock Exchange.</li>
<li>Inpixon (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inpx#NASDAQ">INPX</a>) surged 60% to $1.16 after jumping around 128% on Thursday.</li>
<li>FOXO Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/foxo#NYSE">FOXO</a>) gained 40.5% to $0.7001. FOXO Technology recently announced full year 2022 financial results and recent business highlights.</li>
<li>Petros Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptpi#NASDAQ">PTPI</a>) climbed 35.8% to $1.53.</li>
<li>ICZOOM Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izm#NASDAQ">IZM</a>) gained 35% to $3.58. ICZOOM Group announced upgrade of its AI Customer Service System.</li>
<li>China Natural Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chnr#NASDAQ">CHNR</a>) gained 29.5% to $2.94. China Natural Resources will proceed with acquisition of Lithium Mine in Zimbabwe.</li>
<li>Express, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/expr#NYSE">EXPR</a>) rose 24% to $0.8374 after the company announced it and WHP Global will acquire Bonobos for a combined $75 million.</li>
<li>Bullfrog AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfrg#NASDAQ">BFRG</a>) gained 23% to $6.92.</li>
<li>My Size, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mysz#NASDAQ">MYSZ</a>) jumped 22.3% to $1.8150. MySize posted FY22 revenue of $4.459 million.</li>
<li>Beamr Imaging Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmr#NASDAQ">BMR</a>) gained 21.6% to $1.80.</li>
<li>BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) rose 20% to $3.3498. BigBear.ai recently filed for a mixed shelf offering.</li>
<li>LogicMark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgmk#NASDAQ">LGMK</a>) gained 17.1% to $0.1850 after gaining around 8% on Thursday.</li>
<li>SMX (Security Matters) Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smx#NASDAQ">SMX</a>) shares climbed 16% to $2.62 after jumping 37% on Thursday.</li>
<li>Remark Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mark#NASDAQ">MARK</a>) jumped 15.4% to $1.42.</li>
<li>Purple Innovation, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prpl#NASDAQ">PRPL</a>) gained 15% to $2.5750. Purple Innovation announced cooperative framework with Coliseum Capital.</li>
<li>Abcam plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abcm#NASDAQ">ABCM</a>) gained 14.1% to $15.41.</li>
<li>Cipher Mining Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cifr#NASDAQ">CIFR</a>) jumped 12.2% to $2.9750.</li>
<li>Navidea Biopharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/navb#NASDAQ">NAVB</a>) gained 11.6% to $0.2906. Navidea Biopharmaceuticals entered into $750,000 asset purchase agreement with Meilleur Technologies for rights to NAV4694.</li>
<li>Mind Medicine (MindMed) Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) shares gained 10.4% to $3.4216. Mind Medicine&rsquo;s collaborators have released topline data from a double-blind, investigator-initiated trial evaluating lysergide major depressive disorder (MDD).</li>
<li>NextDecade Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/next#NASDAQ">NEXT</a>) rose 10% to $5.70.</li>
<li>QuidelOrtho Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qdel#NASDAQ">QDEL</a>) gained 9.6% to $98.32. QuidelOrtho Corporation said it expects total revenues in Q1 FY23 to be $840 million-$850 million, compared to the consensus of $746.75 million, driven by the Labs business unit.</li>
<li>JPMorgan Chase &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>) rose 7.2% to $138.30 as the company reported Q1 net revenue (managed) of $39.3 billion, up 25% Y/Y, beating the consensus of $36.2 billion.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Meta Materials Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mmat#NASDAQ">MMAT</a>) fell 42% to $0.22 after the company announced pricing of a $25 million underwritten public offering.</li>
<li>Pear Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pear#NASDAQ">PEAR</a>) shares dropped 37.4% to $0.0741. Pear Therapeutics recently filed for Chapter 11 and said it will seek to sell its assets through a sales process.</li>
<li>T Stamp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idai#NASDAQ">IDAI</a>) fell 31.5% to $3.80 after the company announced pricing of a $5.2 million registered direct offering and concurrent private placement priced at-the-market.</li>
<li>VCI Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcig#NASDAQ">VCIG</a>) dropped 30% to $2.9599.</li>
<li>Goldenbridge Acquisition Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbrg#NASDAQ">GBRG</a>) dropped 28% to $7.50.</li>
<li>GlucoTrack, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gctk#NASDAQ">GCTK</a>) dipped 28% to $0.98. GlucoTrack announced a proposed underwritten offering of common stock.</li>
<li>Catalent, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctlt#NYSE">CTLT</a>) dropped 25% to $47.51 after the company said its gene therapy manufacturing site in Harmans, MD experienced productivity issues and significantly reduced the expected revenue in fiscal Q3 associated with the site and will also impact Q4 sales.</li>
<li>Uxin Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uxin#NASDAQ">UXIN</a>) dropped 24.4% to $1.18.</li>
<li>Kalera Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kal#NASDAQ">KAL</a>) fell 21% to $1.28 after dropping 14% on Thursday. Kalera recently received a notice of delisting form Nasdaq.</li>
<li>Spirit AeroSystems Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spr#NYSE">SPR</a>) dipped 20.3% to $28.33 following a report Boeing will likely halt some 737 deliveries amid an issue with a part made by Spirit.</li>
<li>Alvotech (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alvo#NASDAQ">ALVO</a>) fell 19.1% to $11.07 after the FDA issued a complete response letter for the company&#39;s AVT02 BLA.</li>
<li>SAB Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sabs#NASDAQ">SABS</a>) fell 19% to $0.6150. SAB Therapeutics shares jumped around 98% on Thursday after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza.</li>
<li>Navidea Biopharmaceuticals (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncmi#NASDAQ">NCMI</a>) fell 17.5% to $0.3526. The company recently filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas. The company announced a series of debt restructuring transactions likely to strengthen its balance sheet meaningfully and position it for long-term growth.</li>
<li>ViewRay, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vray#NASDAQ">VRAY</a>) fell 17.5% to $1.51. Stifel, BTIG and Oppenheimer downgraded the stock.</li>
<li>Perma-Fix Environmental Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pesi#NASDAQ">PESI</a>) fell 17.5% to $8.06 after the company issued an update on recent contract awards.</li>
<li>MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) fell 17.3% to $10.76.</li>
<li>D-Wave Quantum Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qbts#NYSE">QBTS</a>) fell 17% to $0.5401. D-Wave Quantum reported fourth-quarter revenues of $2.4 million, flat on a year-over-year basis.</li>
<li>Carrols Restaurant Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tast#NASDAQ">TAST</a>) dropped 16.6% to $2.92.</li>
<li>EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) dipped 12.7% to $10.78.</li>
<li>HeartCore Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htcr#NASDAQ">HTCR</a>) fell 11.7% to $1.28 after dropping 15% on Thursday. HeartCore Enterprises recently announced it signed its tenth Go IPO contract.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teva#NYSE">TEVA</a>) dropped 11.4% to $8.21 after the company announced its partner Alvotech received a complete response letter from the FDA for the Biologics License Application for AVT02.</li>
<li>Hingham Institution for Savings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hifs#NASDAQ">HIFS</a>) fell 11.3% to $207.00 after reporting a decline in Q1 EPS.</li>
<li>Lucid Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcid#NASDAQ">LCID</a>) dropped 8.7% to $7.55 after the company announced Q1 production and delivery totals.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) fell 8% to $0.8918.</li>
<li>Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) fell 7% to $0.54. Panbela Therapeutics recently announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.</li>
<li>The Boeing Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ba#NYSE">BA</a>) shares declined 7% to $198.60 following a report suggesting the company warned of lower 737 Max production and deliveries because of a supplier issue.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/23/04/31806110/wall-streets-most-accurate-analysts-say-sell-these-3-tech-stocks-delivering-high-dividend-yields"> Wall Street&#39;s Most Accurate Analysts Say Sell These 3 Tech Stocks Delivering High-Dividend Yields</a>

Intraday Update

Movers

ABCM

ALVO

BBAI

BFRG

CHNR

CIFR

CTLT

CXAI

EVER

EXPR

FOXO

GBRG

GCTK

HTCR

IDAI

INPX

LCID

Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Comments

Hingham Institution

Hingham Institution (HIFS) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO